Cell and Gene Therapy Theme +2.94%, Scribe Therapeutics Up 27.94%
PickStock AI Summary
- As of the close on 2026-08-19, the cell and gene therapy theme posted an average gain of +2.94%, showing strong relative flow.
- The standout winner was Scribe Therapeutics (SCTX), while some names like ToolGen (199800) lagged, so theme breadth should be checked.
- Data was generated after KOSPI reference day and price outlier guards, and for the next trading day check for sustained volume and widening participation.
TL;DR
- Strong theme at close: Cell and Gene Therapy
- Theme average change: +2.94%
- Leading gainer: Scribe Therapeutics (SCTX) +27.94%
- Laggard in theme: ToolGen (199800) -2.67%
How to read today’s strength in the cell and gene therapy theme
The cell and gene therapy theme covers companies developing and commercializing treatments that edit genes or manipulate cells to treat disease. Key areas include CAR-T, gene editing, viral vectors, cell therapy manufacturing, and process technologies.
Today the theme averaged +2.94%. To determine whether this was a single-stock event or a broader theme rotation, compare moves among leaders and laggards.
Stock-level moves
| Stock | Market | Change | Checkpoint |
|---|---|---|---|
| Scribe Therapeutics (SCTX) | NASDAQ | +27.94% | A biotech developing a gene editing based therapeutic platform. |
| Obsidian Therapeutics, Inc. (OBX) | NASDAQ | +13.74% | Develops engineered cell therapies and other cell and gene treatments. |
| Sillajen (215600) | KOSDAQ | +8.04% | Holds oncolytic virus and immunotherapy platforms related to gene delivery and oncoimmuno treatments |
| Gilead (GILD) | NASDAQ | +3.25% | Expanded cell therapy, especially CAR-T, via acquisition of Kite Pharma |
| Novartis (NVS) | NYSE | +1.70% | Developer of Kymriah, the first commercial CAR-T, and a leader in cell therapies |
| Editas Medicine (EDIT) | NASDAQ | +1.41% | One of the US-listed companies leading CRISPR based gene editing therapeutics development |
Checklist for the next trading day
- Confirm whether the rally was accompanied by rising trading volume.
- Separate names that held gains into the close from those with long upper wicks.
- Check if US session ETFs or peers are continuing the move.
- Look for under-rotated names within the theme, distinguishing simple low-price rotation from structural momentum.
Learn more
- View cell and gene therapy related and leading stocks
- Market close briefing: PickStock Insights
- Explore the theme map: Mindmap
Published: 2026-08-19 16:40 KST. Data sources: PickStock theme DB, Yahoo Finance price cache. Generated after checking price outliers and daily index reference; for information only, not investment advice.
관련 테마의 대표 기업을 확인하고, 내 관심 종목은 뉴스·시그널·시장 맥락으로 이어서 볼 수 있습니다.
종목명을 입력하면 재무, 뉴스, 시장 데이터를 정보 제공용 점검 리포트로 정리합니다.
관심 테마로 저장하면 마이페이지에서 다시 볼 수 있고, 강한 움직임이 생길 때 주간 테마 시그널과 연결해 확인할 수 있습니다.
